Compare CSX Corporation (CSX) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Humana Inc — how do they compare? CSX Corporation trades at $47.26 (market cap $87.70B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: CSX Corporation is the larger of the two by market cap, and CSX Corporation pays the higher dividend (1.18%). Which is the better fit depends on your goals — on Pluang, investors hold CSX Corporation for 55 Days and Humana Inc for 51 Days on average.
| CSX | HUM | |
|---|---|---|
Market Cap | $87.70B | $46.49B |
Volume | 6,980,781 | 2,567,704 |
Sector | Industrials | Health |
52-Week High | $53.21 | $409.85 |
52-Week Low | $33.68 | $163.67 |
Typical Hold Time | 55 Days | 51 Days |
Enterprise Value | $105.66B | $53.84B |
Dividend Yield | 1.18% | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CSX trades at $47.34, up 1.13% today, with a bullish technical signal and strong institutional interest. Recent earnings beat expectations in Q1 and Q2 2026, though revenue and net income have declined since 2022. The stock is supported by a 58.69% analyst buy rating and a consensus price target of $51.00, with upcoming Q3 2026 earnings on October 21, 2026, as a key catalyst.
The outlook is positive due to pricing power in freight rail and dividend growth, but risks include declining profit margins, high debt levels, and economic sensitivity. Upside potential exists if earnings rebound, yet valuation multiples are elevated, warranting caution near-term.
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
